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Intestinal tracts of broilers and turkeys from 10 conventional broiler farms and 10 conventional turkey
farms, where antimicrobials were routinely used, and from 5 organic broiler farms and 5 organic turkey farms,
where antimicrobials had never been used, were collected and cultured for Campylobacter species. A total of 694
Campylobacter isolates from the conventional and organic poultry operations were tested for antimicrobial
resistance to nine antimicrobial agents by the agar dilution method. Although Campylobacter species were
highly prevalent in both the conventional and organic poultry operations, the antimicrobial resistance rates
were significantly different between the organic operations and the conventional operations. Less than 2% of
Campylobacter strains isolated from organically raised poultry were resistant to fluoroquinolones, while 46%
and 67% of Campylobacter isolates from conventionally raised broilers and conventionally raised turkeys,
respectively, were resistant to these antimicrobials. In addition, a high frequency of resistance to erythromycin
(80%), clindamycin (64%), kanamycin (76%), and ampicillin (31%) was observed among Campylobacter isolates
from conventionally raised turkeys. None of the Campylobacter isolates obtained in this study was resistant to
gentamicin, while a large number of the isolates from both conventional and organic poultry operations were
resistant to tetracycline. Multidrug resistance was observed mainly among Campylobacter strains isolated from
the conventional turkey operation (81%). Findings from this study clearly indicate the influence of conventional
and organic poultry production practices on antimicrobial resistance of Campylobacter on poultry farms.
Food-borne campylobacteriosis, a major public health con-
cern in the United States and many countries worldwide, is
caused mainly by Campylobacter jejuni (23). It is estimated that
more than 2 million cases of food-borne bacterial diarrhea that
occur each year in the United States are caused by Campy-
lobacter (3). In other industrialized countries, the numbers of
Campylobacter infections exceeded those of Salmonella, Shi-
gella, and Escherichia coli O157:H7 infections combined (2).
Campylobacter jejuni not only is an important cause of bacterial
gastroenteritis in humans but also has been associated with
Guillain-Barre´ syndrome, an acute immune-mediated demy-
elinating disorder of the peripheral nervous system (7, 24).
Although most Campylobacter infections in humans are asso-
ciated with ingestion of contaminated or improperly handled/
cooked foods as well as milk or dairy products, consumption of
undercooked poultry and/or other foods that are cross-contam-
inated with raw poultry meat during food preparation is con-
sidered a major risk factor for food-borne campylobacteriosis
(4, 7). Since thermophilic Campylobacter spp., including C.
jejuni and Campylobacter coli, are highly prevalent in chickens
and turkeys (29, 34), contamination of poultry carcasses by
Campylobacter during processing in slaughter houses occurs
frequently, resulting in the potential transmission of Campy-
lobacter from contaminated poultry meats to consumers.
Over the last decade, the emergence of antimicrobial resis-
tance in Campylobacter strains isolated from humans and ani-
mals in many countries around the world has increased dra-
matically (12, 17, 25, 39, 43). In the United States, the prevalence
of fluoroquinolone resistance among Campylobacter isolates in-
creased significantly from 1.3% in 1992 to 8% to 13% during 1996
to 1998, and this resistance trend has increased steadily since 1998
(15, 26, 37). In 2001, the National Antimicrobial Resistance Mon-
itoring System (NARMS) and Nachamkin et al. found that about
19% to 40% ofCampylobacter strains isolated from humans in the
United States were resistant to ciprofloxacin (15, 26). The emer-
gence of antimicrobial resistance, particularly among food-borne
pathogens, is in part because of the widespread use of antimicro-
bial agents in both humans and animals (17, 22, 39, 40, 43).
In conventional production practice, antimicrobial agents
can be used for treatment, control, and prevention of the
diseases as well as for improvement of growth and feed effi-
ciency of the animals (17, 22, 39, 40). Organic production
practice, on the other hand, has restricted the use of antimi-
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crobial substances on the farms (11). In addition to being
subjected to the strict rules regarding the use of antimicrobial
substances, the organic birds must be fed only on organically
produced feed and supplements. Moreover, these organic
birds must be provided with uncrowded living areas, and they
also need to have access to fresh air, sunlight, and the outside
environment (11). Although many studies of antimicrobial re-
sistance in conventional poultry operations have been done,
relatively little is known about antimicrobial-resistant Campy-
lobacter in organic poultry operations. Since no antimicrobials
have been used in the organic poultry operations and the
demand for organic animal produce has been increasing con-
siderably over the last several years (10), the difference in
antimicrobial resistance of Campylobacter isolates from con-
ventional and organic poultry operations is of interest. In
addition, despite the recent advances in understanding the
epidemiology of antimicrobial-resistant Campylobacter, rela-
tively little is known about the impact of conventional and
organic animal production practices on the prevalence of anti-
microbial-resistant Campylobacter. Therefore, the purpose of this
study was to determine the prevalence and antimicrobial resis-
tance of Campylobacter isolates from both conventionally raised
and organically raised broilers and turkeys.
MATERIALS AND METHODS
Sample collection. This study focused on the prevalence of antimicrobial-
resistant Campylobacter in slaughter-age birds. A total of 345 broiler and 360
turkey intestinal tracts originating from 10 conventional broiler farms and 10
conventional turkey farms were collected from processing plants, which process
approximately 200,000 to 300,000 broilers and 17,000 to 21,000 turkeys per week.
Since there are only a limited number of large-scale certified organic broiler and
turkey farms in Ohio, only five organic broiler farms and five organic turkey
farms were included in this study. A total of 355 intestinal tracts of organic
broilers and 230 intestinal tracts of organic turkeys were collected from a state-
inspected organic processing plant. In general, the whole intestinal tract of
conventionally raised turkeys, organically raised broilers, and organically raised
turkeys was manually taken out from each carcass by an employee of the pro-
cessing plant, while the whole intestinal tract of conventionally raised broilers
was taken out from each carcass by automated equipment. The samples in this
study were collected from August 2000 to November 2002.
Antimicrobial usage data. According to direct interviews with farmers, no
antimicrobial agents were used in organic broiler or turkey operations from
which the samples were collected. In contrast, antimicrobial agents were used in
almost every conventional poultry farm according to direct interviews with farm-
ers or production supervisors. For conventionally raised broilers, gentamicin was
the most commonly used antimicrobial. This antimicrobial agent was given to the
birds at the hatchery to prevent early mortality due to E. coli infections. In
addition to gentamicin, lincomycin was also used in some conventional broiler
farms to prevent as well as to treat necrotic enteritis in conventionally raised
broilers, at a dosage of 2 to 4 g/ton feed for prevention or 64 mg/gallon water for
5 to 10 days for treatment. If these conventional broiler flocks had coccidiosis,
they were treated with amprolium at 0.004% in feed continuously or at 0.024%
in water for 3 to 5 days. In addition, bacitracin and virginiamycin, which were
supplemented in broiler feed at subtherapeutic levels in order to promote growth
and improve feed efficiency as well as to prevent and control necrotic enteritis,
were also used in these conventional broiler farms. If bacitracin was used for
prevention of necrotic enteritis, it was given to the birds at a dosage of 100
mg/gallon water. But, if it was used for control of the disease, this antimicrobial
agent was used at a dosage of 200 to 400 mg/gallon water. Virginiamycin was
used to prevent necrotic enteritis in these conventionally raised broilers at a
dosage of 5 to 15 g/ton feed. For the conventional broiler flocks surveyed in this
study, the birds were not exposed to treatments with fluoroquinolones during the
production period, according to information obtained from the producers; how-
ever, fluoroquinolones were used in the previous flocks of these conventional
broiler farms. For conventionally raised turkeys, enrofloxacin was the drug rou-
tinely used for flocks with respiratory disease due to E. coli infections, while
chlortetracycline was used only for the farms that had a high prevalence of fowl
cholera. As with the conventionally raised broilers, bacitracin was also used as a
feed additive and used to control necrotic enteritis in conventionally raised
turkeys at a dosage of 400 mg/gallon water for 5 to 7 days.
Bacterial isolation and identification. The intestinal tracts were placed on ice
and brought back to the laboratory within 3 h of collection and cultured for
Campylobacter species. Each cecum was aseptically opened, and cecal contents
were streaked onto Campy CVA agar containing cefoperazone, vancomycin, and
amphotericin B as selective supplements (BBL Becton Dickinson Microbiology
Systems, Cockeysville, MD) with a sterile cotton swab. The inoculated plates were
then incubated at 42°C for 48 h in a microaerophilic environment (approximately 5%
O2, 10% CO2, and 85% N2) in an anaerobic system jar with gas-generating system
envelopes (BBL Becton Dickinson Microbiology Systems, Sparks, MD). Suspect
Campylobacter colonies were identified by colony morphology characteristics, Gram
stain, an oxidase test, a catalase test, and a Campylobacter culture plate latex agglu-
tination confirmation test (INDX-Campy [jcl]; PanBio InDx, Inc., Baltimore, MD).
The hippurate hydrolysis test was performed to differentiate C. jejuni from C. coli
and otherCampylobacter species. From eachCampylobacter-positive sample, a single
colony was used for an antimicrobial susceptibility test. All Campylobacter isolates
were stored in sterile cryovial tubes containing skim milk and 30% glycerol at85°C
prior to the antimicrobial susceptibility test.
Antimicrobial susceptibility testing. A total of 694 Campylobacter isolates
from conventional and organic poultry farms were tested for antimicrobial re-
sistance to nine antimicrobial agents, including ampicillin, tetracycline, gentami-
cin, kanamycin, clindamycin, erythromycin, ciprofloxacin, norfloxacin, and nali-
dixic acid, by the agar dilution method (27). All antimicrobial agents were
obtained from Sigma Chemical Co., St. Louis, MO, except ciprofloxacin (Sero-
logicals Proteins, Inc., Kankakee, IL). The concentrations of most antimicrobial
agents tested in this study ranged from 0.06 to 128 g/ml except for ciprofloxacin
(0.008 to 128 g/ml) and for kanamycin and nalidixic acid (0.25 to 128 g/ml)
(Table 1). Briefly, Campylobacter isolates grown on blood agar plates for 48 h
were inoculated onto Mueller-Hinton broth and then adjusted to a turbidity
equivalent to a 0.5 McFarland standard by a colorimeter. A multipoint inoculator
(a Cathra replicator system) with 1-mm pins (Oxoid, Inc., Ogdensburg, NY) was
used to inoculate approximately 104 CFU of samples onto Mueller-Hinton agar
containing a twofold concentration series of antimicrobials and supplemented
with 5% defibrinated sheep blood. Campylobacter jejuni ATCC 33560 was used
as the quality control organism (27). While quality control ranges are not cur-
rently available for ampicillin, kanamycin, clindamycin, and norfloxacin, the MIC
results for these drugs with C. jejuni ATCC 33560 were consistent, falling within
a three-dilution range throughout the study. The inoculated plates were incu-
bated in a CO2 incubator (Thermo Electron Corporation, Marietta, OH) at 42°C
for 24 h in a microaerophilic atmosphere of 5% O2, 10% CO2, and 85% N2. The
MIC was defined as the lowest concentration of antimicrobial agent that com-
pletely inhibited the visible growth on the plates. The resistance breakpoints for
the antimicrobial agents were as follows: 4 g/ml for ciprofloxacin and clinda-
mycin, 8 g/ml for erythromycin, 16 g/ml for tetracycline, gentamicin, and
TABLE 1. Antimicrobial test ranges, MIC quality control ranges,














Ampicillin 0.06–128 N/Ac 8 16 32
Tetracycline 0.06–128 1–4 4 8 16
Gentamicin 0.06–128 0.5–4 4 8 16
Kanamycin 0.25–128 N/A 16 32 64
Clindamycin 0.06–128 N/A 0.5 1–2 4
Erythromycin 0.06–128 1–8 0.5 1–4 8
Ciprofloxacin 0.008–128 0.06–0.5 1 2 4
Norfloxacin 0.06–128 N/A 4 8 16
Nalidixic acid 0.25–128 8–32 16 32
a MIC breakpoints for enteric bacteria for all agents except norfloxacin were
used by the NARMS. MIC breakpoints for Enterobacteriaceae for norfloxacin
were recommended by the CLSI (formerly NCCLS). S, susceptible strains; I, in-
termediate strains; R, resistant strains.
b Tentative agar dilution quality control ranges of C. jejuni ATCC 33560 were
approved by the CLSI.
c N/A, no data available.
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norfloxacin, 32 g/ml for ampicillin and nalidixic acid, and 64 g/ml for
kanamycin (Table 1) (8, 28). If an isolate was resistant to three or more classes
of antimicrobials, it was defined as multidrug resistant.
Statistical analysis. A chi-square test at a P significance level of 0.05 (two
tailed), with Yates’ correction for continuity, was used for comparing the prev-
alence and antimicrobial resistance rates of Campylobacter isolates between
conventional and organic operations and between broilers and turkeys.
RESULTS
Prevalence of Campylobacter. The prevalence of C. jejuni and
C. coli plus other Campylobacter species in conventionally
raised broilers was 66%, while the prevalence of these organ-
isms in conventionally raised turkeys was 83%. In terms of the
organic poultry production systems, the prevalences of Campy-
lobacter spp. in organically raised broilers and organically
raised turkeys were 89% and 87%, respectively (Table 2). On
the basis of the hippurate hydrolysis test, C. jejuni was the
predominant Campylobacter species in conventionally raised
broilers, organically raised broilers, and organically raised tur-
keys, whereas C. coli and other Campylobacter species were the
predominant species in conventionally raised turkeys (Table
TABLE 2. Prevalence and antimicrobial resistance of C. jejuni and C. coli plus other Campylobacter species
in conventional and organic broiler and turkey farms
Farma No. (%) of positive samples/total no. of samplesb
No. (%) of positive samples Major antimicrobial
resistance patterndC. jejuni C. colic
CB-1 20 (66.67)/30 20 (100) 0 (0) TET or FQ
CB-2 14 (56.00)/25 14 (100) 0 (0) TET-KAN-FQ
CB-3 23 (76.63)/30 23 (100) 0 (0) TET
CB-4 22 (73.33)/30 22 (100) 0 (0) TET
CB-5 30 (66.67)/45 23 (76.67) 7 (23.33) TET-FQ
CB-6 27 (67.50)/40 27 (100) 0 (0) TET
CB-7 24 (60.00)/40 24 (100) 0 (0) TET-FQ
CB-8 16 (53.33)/30 16 (100) 0 (0) TET or TET-FQ
CB-9 11 (44.00)/25 11 (100) 0 (0) TET or KAN
CB-10 40 (80.00)/50 40 (100) 0 (0) TET or TET-FQ
Total 227 (65.80)/345 220 (96.92) 7 (3.08)
OB-1 85 (91.40)/93 53 (62.35) 32 (37.65) TET
OB-2 82 (88.17)/93 61 (74.39) 21 (25.61) TET or TET-KAN
OB-3 22 (81.48)/27 13 (59.09) 9 (40.91) KAN or TET-KAN
OB-4 96 (100)/96 70 (72.92) 26 (27.08) No resistancee
OB-5 32 (69.57)/46 32 (100) 0 (0) TET
Total 317 (89.30)/355 229 (72.24) 88 (27.76)
CT-1 20 (66.67)/30 8 (40) 12 (60) TET-KAN-CLI-ERY f
CT-2 39 (86.67)/45 7 (17.95) 32 (82.05) TET-KAN-CLI-ERY-FQ
CT-3 44 (97.78)/45 17 (38.64) 27 (61.36) TET-KAN-CLI-ERY-FQ g
CT-4 24 (80.00)/30 16 (66.67) 8 (33.33) TET-KAN-CLI-ERY-FQ
CT-5 19 (63.33)/30 11 (57.89) 8 (42.11) TET-KAN-CLI-ERY-FQ
CT-6 40 (88.89)/45 26 (65) 14 (35) TET-KAN-CLI-ERY-FQ g
CT-7 21 (70.00)/30 11 (52.38) 10 (47.62) TET
CT-8 29 (96.67)/30 16 (55.17) 13 (44.83) KAN-ERYh
CT-9 21 (70.00)/30 12 (57.14) 9 (42.86) No specific patterni
CT-10 42 (93.33)/45 13 (30.95) 29 (69.05) TET-KAN-CLI-ERY-FQ g
Total 299 (83.06)/360 137 (45.82) 162 (54.18)
OT-1 40 (93.02)/43 20 (50) 20 (50) TET
OT-2 42 (100)/42 33 (78.57) 9 (21.43) TET or TET-KAN
OT-3 88 (93.62)/94 49 (55.68) 39 (44.32) KAN or TET-KAN
OT-4 1 (5.56)/18 1 (100) 0 (0) TET
OT-5 30 (90.91)/33 30 (100) 0 (0) TET-KAN j
Total 201 (87.39)/230 133 (66.17) 68 (33.83)
a CB, conventional broiler farm; OB, organic broiler farm; CT, conventional turkey farm; OT, organic turkey farm.
b Number (%) of intestines positive for Campylobacter species/number of intestines isolated for Campylobacter species.
c Number (%) of intestines positive for C. coli and other Campylobacter species.
d CLI, clindamycin; ERY, erythromycin; FQ, fluoroquinolones; KAN, kanamycin; TET, tetracycline.
e None of the Campylobacter isolates was resistant to antimicrobial agents tested in this study.
f Some isolates were also resistant to fluoroquinolones and ampicillin.
g Some isolates were also resistant to ampicillin.
h Some isolates were also resistant to fluoroquinolones and tetracycline.
i No major antimicrobial resistance pattern was observed.
j Only one isolate from this organic turkey farm was resistant to tetracycline and kanamycin, while the rest of the isolates were susceptible to all antimicrobial agents.
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isolatesd0.06 0.125 0.25 0.5 1 2 4 8 16 32 64 128 128
Ampicillin Conventionalb 0 0 0 0 0 5 98 74 33 22 2 4 2 8/32 30 (12.50)
Organicc 0 0 0 0 1 39 80 24  56 ❙ 4 4 3 0 4/16 11 (4.58)†
Tetracycline Conventional 0 8 5 2 6 0 2 4 12 60 51 66 24 64/128 213 (88.75)
Organic 0 7 35 42 13 4 0  0 ❙ 7 15 25 28 35 16/128 110 (52.13)†
Gentamicin Conventional 0 0 23 93 122 2 0 0 0 0 0 0 0 1/1 0
Organic 0 0 39 100 72 0 0  0 ❙ 0 0 0 0 0 0.5/1 0
Kanamycin Conventional 1 0 0 9 72 91 3 1 0 1 62 8/128 63 (26.25)
Organic 0 0 6 20 69 86 1  0 ❙ 0 0 29 8/128 29 (13.74)†
Clindamycin Conventional 0 0 1 37 127 38 4 3 1 25 4 0 0 1/32 37 (15.42)
Organic 0 0 1 65  110 30 ❙ 0 0 1 4 0 0 0 1/2 5 (2.37)†
Erythromycin Conventional 0 0 1 3 54 107 29 4 4 1 1 2 34 2/128 46 (19.17)
Organic 0 2 1 37  71 78 17 ❙ 0 0 0 0 0 5 1/4 5 (2.37)†
Ciprofloxacin Conventional 0 45 37 19 10 1 0 20 80 28 0 0 0 8/32 128 (53.33)
Organic 1 51 65 49 38  5 ❙ 0 0 0 0 2 0 0 0.25/1 2 (0.95)†
Norfloxacin Conventional 0 0 9 58 34 8 0 2 0 1 48 75 5 64/128 129 (53.75)
Organic 0 5 77 74 41 7 5  0 ❙ 0 0 0 0 2 0.5/1 2 (0.95)†
Nalidixic acid Conventional 0 0 2 3 56 29 20 0 1 22 107 128/128 130 (54.17)
Organic 0 0 0 7 135 60 7 ❙ 0 0 0 2 4/8 2 (0.95)†
a Thin vertical lines indicate the breakpoint between susceptible and intermediate strains. Thick vertical lines indicate the breakpoint between intermediate and
resistant strains (except for nalidixic acid, for which it indicates the breakpoint between susceptible and resistant strains).
b C. jejuni isolates from conventional poultry farms (n  240).
c C. jejuni isolates from organic poultry farms (n  211).
d Different symbols between operation types (conventional and organic) indicate a significant difference (P  0.05) by a chi-square test with Yates’ correction for
continuity.
TABLE 4. MIC distributions and resistance rates of C. coli and other Campylobacter species isolated









isolatesd0.06 0.125 0.25 0.5 1 2 4 8 16 32 64 128 128
Ampicillin Conventionalb 0 0 0 0 0 0 5 58 32 9 2 19 3 16/128 33 (25.78)
Organicc 0 0 0 0 0 0 20 41  50 ❙ 0 0 4 0 8/16 4 (3.49)†
Tetracycline Conventional 0 0 0 1 7 4 2 0 1 0 13 63 37 128/128 114 (89.06)
Organic 0 0 3 19 21 2 0  0 ❙ 2 14 1 7 46 32/128 70 (60.87)†
Gentamicin Conventional 0 0 2 18 107 1 0 0 0 0 0 0 0 1/1 0
Organic 0 0 7 37 71 0 0  0 ❙ 0 0 0 0 0 1/1 0
Kanamycin Conventional 0 0 0 1 4 9 5 0 0 0 109 128/128 109 (85.16)
Organic 0 0 0 0 10 50 5  1 ❙ 0 0 49 8/128 49 (42.61)†
Clindamycin Conventional 0 0 0 5 21 9 4 7 4 72 6 0 0 32/32 93 (72.66)
Organic 0 0 0 52  35 19 ❙ 1 0 1 5 2 0 0 1/2 9 (7.83)†
Erythromycin Conventional 0 0 2 0 1 3 8 8 6 5 1 2 92 128/128 114 (89.06)
Organic 0 1 13 17  10 35 24 ❙ 7 0 0 0 0 8 2/8 15 (13.04)†
Ciprofloxacin Conventional 0 3 14 10 17 0 1 2 13 60 7 1 0 32/32 84 (65.63)
Organic 0 4 38 29 39  4 ❙ 0 0 0 0 1 0 0 0.5/1 1 (0.87)†
Norfloxacin Conventional 0 0 3 12 20 9 0 2 0 1 37 41 3 64/128 82 (64.06)
Organic 0 0 4 70 35 4 1  0 ❙ 0 0 0 0 1 0.5/1 1 (0.87)†
Nalidixic acid Conventional 0 0 0 0 5 24 17 0 1 22 59 128/128 82 (64.06)
Organic 0 0 0 0 61 45 8 ❙ 0 0 0 1 4/8 1 (0.87)†
a Thin vertical lines indicate the breakpoint between susceptible and intermediate strains. Thick vertical lines indicate the breakpoint between intermediate and
resistant strains (except for nalidixic acid, for which it indicates the breakpoint between susceptible and resistant strains).
b Campylobacter isolates from conventional poultry farms (n  128).
c Campylobacter isolates from organic poultry farms (n  115).
d Different symbols between operation types (conventional and organic) indicate a significant difference (P  0.05) by a chi-square test with Yates’ correction for
continuity.
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2). In this study, Campylobacter spp. could be isolated from
every conventional and organic broiler and turkey farm. The
prevalence of Campylobacter spp. in conventional broiler farms
ranged from 44% to 80%, while the prevalence of these or-
ganisms in conventional turkey farms ranged from 63% to
98%. Likewise, the prevalence of Campylobacter spp. ranged
from 70% to 100% in organic broiler farms and 6% to 100% in
organic turkey farms (Table 2).
Antimicrobial resistance patterns. The MIC distributions
and the MICs at which 50% and 90% of C. jejuni and C. coli
plus other Campylobacter species were inhibited are summa-
rized in Tables 3 and 4. In general, a wider range of MICs of
most antimicrobials was observed mainly among Campylo-
bacter isolates from conventional poultry farms than among the
isolates from organic poultry farms, except the MIC of genta-
micin, for which the lowest concentrations of this antimicrobial
agent against Campylobacter strains isolated from both opera-
tion types were comparable. When the MIC90 and the resis-
tance breakpoint of each antimicrobial agent were compared,
the MIC90 values of ampicillin, clindamycin, erythromycin, cip-
rofloxacin, norfloxacin, and nalidixic acid for Campylobacter
isolates from conventionally raised broilers and turkeys were
higher than their resistance breakpoints, while the MIC90 val-
ues of these antimicrobials for the isolates from organically
raised broilers and turkeys were lower than the resistance
breakpoints. Overall, the MIC90 values of these antimicrobial
agents for Campylobacter strains isolated from conventional
poultry farms were higher than those for the strains isolated from
organic poultry farms (Tables 3 and 4). Although Campylobacter
strains isolated from both conventional and organic poultry op-
erations in this study were uniformly susceptible to gentamicin,
with an MIC90 of 1 g/ml, these Campylobacter isolates were
highly resistant to tetracycline, with an MIC90 of 128 g/ml.
One of the most striking findings in this study was the dif-
ference in quinolone and fluoroquinolone resistance between
Campylobacter strains isolated from conventional poultry
farms and organic poultry farms. Approximately 46% of
Campylobacter strains isolated from conventionally raised
broilers and 67% of Campylobacter strains isolated from con-
ventionally raised turkeys were resistant to ciprofloxacin, nor-
floxacin, and nalidixic acid. In contrast, none of the Campy-
lobacter strains isolated from organically raised broilers and
less than 2% of Campylobacter strains isolated from organically
raised turkeys were resistant to these antimicrobials (Table 5).
Compared to Campylobacter strains isolated from convention-
ally raised broilers and organically raised broilers and turkeys,
the isolates from the conventional turkey operation were sig-
nificantly more resistant to erythromycin, clindamycin, kana-
mycin, tetracycline, and ampicillin (P  0.05) (Table 5). Re-
gardless of the sources of isolation, none of the Campylobacter
strains tested in this study were resistant to gentamicin, while
more than 80% of Campylobacter strains isolated from con-
ventionally raised broilers and turkeys and 50% to 60% of
Campylobacter strains isolated from organically raised broilers
and turkeys were resistant to tetracycline (Table 5). In terms of
multidrug resistance, the occurrence of multidrug-resistant
Campylobacter strains was observed mainly among the isolates
from conventionally raised turkeys, with 81% of these isolates
showing resistance to three or more classes of antimicrobials
(Table 6). Moreover, about 58% of Campylobacter isolates
TABLE 5. Resistance rates of Campylobacter strains isolated from different poultry production systems
Antimicrobial
agent









Ampicillin 0 A 5 (3.03) A 63 (31.34) B 10 (6.21) A
Tetracycline 141 (84.43) A 99 (60) B 186 (92.54) C 81 (50.31) B
Gentamicin 0 0 0 0
Kanamycin 19 (11.38) A 28 (16.97) A 153 (76.12) B 50 (31.06) C
Clindamycin 2 (1.20) A 9 (5.45) A 129 (64.18) B 5 (3.11) A
Erythromycin 0 A 15 (9.09) B 160 (79.60) C 5 (3.11) D
Ciprofloxacin 76 (45.51) A 0 B 136 (67.66) C 3 (1.86) B
Norfloxacin 77 (46.11) A 0 B 134 (66.67) C 3 (1.86) B
Nalidixic acid 77 (46.11) A 0 B 135 (67.16) C 3 (1.86) B
a Antimicrobial resistance rates of Campylobacter isolates from different poultry production systems are compared by a chi-square test with Yates’ correction for
continuity. Numbers in the same row with different letters are significantly different (P  0.05), while numbers with the same letters do not differ significantly.
TABLE 6. Major multidrug resistance patterns of C. jejuni and C. coli plus other Campylobacter species isolated
from conventional and organic poultry operations
Operation type (no. of isolates)
No. (%) of multidrug-resistant strains
Resistance patternb
C. jejuni C. colia Total
Conventional broiler farms (167) 15 (8.98) 0 15 (8.98) TET-KAN-CIP-NOR-NAL
Organic broiler farms (165) 4 (2.42) 7 (4.24) 11 (6.67) TET-KAN-CLI-ERY
Conventional turkey farms (201) 59 (29.35) 104 (51.74) 163 (81.09)c TET-KAN-CLI-ERY-CIP-NOR-NAL
Organic turkey farms (161) 4 (2.48) 4 (2.48) 8 (4.97) TET-KAN-CLI-ERY
a C. coli and other Campylobacter species.
b AMP, ampicillin; CIP, ciprofloxacin; CLI, clindamycin; ERY, erythromycin; KAN, kanamycin; NAL, nalidixic acid; NOR, norfloxacin; TET, tetracycline.
c The prevalence of multidrug-resistant Campylobacter strains in conventionally raised turkeys was significantly higher (P  0.05) than that of other operation types.
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from conventionally raised turkeys were resistant to both
erythromycin and ciprofloxacin, whereas none of the Campy-
lobacter strains isolated from conventionally raised broilers and
organically raised broilers and turkeys was concomitantly re-
sistant to these antimicrobial agents. When antimicrobial re-
sistance in individual conventional and organic broiler and
turkey farms was investigated, tetracycline resistance was the
major resistance pattern observed in almost every conventional
broiler farm, organic broiler farm, and organic turkey farm
(Table 2). Unlike the isolates from conventionally raised
broilers and organically raised broilers and turkeys, the ma-
jority of Campylobacter isolates from 6 out of 10 conven-
tional turkey farms were multidrug resistant to tetracycline,
kanamycin, clindamycin, erythromycin, and fluoroquinolo-
nes (Table 2).
DISCUSSION
In this study, it is clearly shown that thermophilic Campy-
lobacter is highly prevalent in both organic and conventional
poultry production systems. However, the antimicrobial resis-
tance rates vary significantly in different production types. In
general, conventionally raised broilers and turkeys harbor
more antimicrobial-resistant Campylobacter strains than organ-
ically raised broilers and turkeys, and the differences are ob-
vious with fluoroquinolones. The highest resistance rates and
multidrug resistance to three or more classes of antimicrobials
are observed mainly among the isolates from the conventional
turkey operation.
Although the prevalences of Campylobacter species in con-
ventionally raised broilers and organically raised broilers were
significantly different (P  0.05), it should be noted that the
average ages of the birds at the processing plants were not the
same. Since the average market age of these organically raised
broilers was about 8 to 12 weeks old, compared to 6 weeks
old for conventionally raised broilers, the high prevalence of
Campylobacter strains in organically raised broilers in part
seems to be associated with the increased age of the birds at
slaughter. The prevalences of Campylobacter species in con-
ventionally raised and organically raised turkeys, on the other
hand, were not significantly different (P  0.19). This is likely
because conventionally raised turkeys and organically raised
turkeys were sent to the processing plants at approximately
the same age (18 to 20 weeks). The association between the
Campylobacter colonization rate and the age of the birds at the
processing plant was also noted by other studies, which indi-
cated that the prevalence of Campylobacter in poultry elevated
when the age of the birds at the processing plant increased (6,
13, 29, 30). Besides the market age of the birds, other factors
such as environmental exposure, which is seen particularly in
organic poultry operations, can also play a role in the preva-
lence of Campylobacter in poultry (16, 29).
Although Campylobacter spp. could be isolated from every
conventional and organic poultry farm, it should be noted that
the prevalences of these organisms varied among farms. Among
Campylobacter-positive flocks, C. jejuni was the predominant spe-
cies in both conventional broiler farms and organic broiler farms,
although the prevalence of C. jejuni in conventionally raised broil-
ers was significantly higher (P  0.05) than that in organically
raised broilers. The high prevalence of C. jejuni in conventionally
raised and organically raised broilers was also reported in other
studies (5, 6, 13, 16, 42). In contrast, the predominant Campy-
lobacter species in the conventional turkey operation was different
from that in the organic turkey operation. C. coli and other
Campylobacter species were the predominant species in conven-
tionally raised turkeys, while C. jejuni was the predominant spe-
cies in organically raised turkeys. Although C. coli and other
Campylobacter species are the predominantCampylobacter strains
isolated from conventionally raised turkeys in this study, it should
be noted that the distributions of C. jejuni and C. coli plus other
Campylobacter species in the conventional turkey operation are
remarkably different among studies. As mentioned earlier,
about 46% and 54% of Campylobacter isolates from conven-
tionally raised turkeys in this study were identified as C.
jejuni and C. coli plus other Campylobacter species, respec-
tively, while Wallace et al. reported that almost 100% of
Campylobacter isolates from conventional turkey flocks were
C. jejuni (41). In contrast, Smith et al. revealed that 80% to
90% of Campylobacter strains colonizing turkey flocks were
C. coli (36).
A significant difference (P  0.001) in quinolone and fluo-
roquinolone resistance rates between Campylobacter strains
isolated from conventional poultry operations and organic
poultry operations was observed in this study. Since fluoro-
quinolones are used for therapeutic purpose only, it is not
unusual that some conventional broiler and turkey flocks in
this study were not treated with these antimicrobial agents.
Although no fluoroquinolones were used in the conventional
broiler flocks from which the samples were collected, they were
used in previous flocks. In addition, because certain quinolone-
resistant clones were stable and able to persist on the farms
during several rotations even though there had been no selec-
tive pressure on that farm for a long period of time (31, 32) and
because fluoroquinolone-resistant Campylobacter strains could
out-compete fluoroquinolone-susceptible Campylobacter strains
in the absence of antimicrobial usage (21), it is not surprising
that a high fluoroquinolone resistance rate was observed
among Campylobacter strains isolated from conventionally
raised broilers in this study. This finding is consistent with
previous studies by Pedersen and Wedderkopp and Price et al.,
who also reported that fluoroquinolone-resistant Campy-
lobacter isolates continued to persist in the flocks that did not
use these antimicrobial agents (31, 32). Since fluoroquinolones
have never been used in organic poultry operations, it is not
surprising that there was little or no resistance to this class of
antimicrobials in Campylobacter strains isolated from organic
poultry farms.
Compared to Campylobacter strains isolated from organic
poultry operations, both C. jejuni and C. coli plus other Campy-
lobacter species isolated from conventional poultry operations,
particularly the isolates from conventionally raised turkeys,
had significantly higher resistance rates (P  0.05) not only to
quinolone and fluoroquinolones but also to erythromycin, clin-
damycin, kanamycin, tetracycline, and ampicillin than the iso-
lates from organically raised poultry. The high prevalence of
multidrug-resistant Campylobacter strains observed in almost
every conventional turkey farm in this study is interesting, since
not all antimicrobial agents to which Campylobacter isolates
from conventionally raised turkeys were resistant were used in
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those conventional turkey farms. However, due to the persis-
tence and transmission of antimicrobial-resistant Campy-
lobacter isolates, the antimicrobial resistance rate in a partic-
ular flock may not be directly correlated with the antimicrobial
usage data. The occurrence of multidrug resistance among
Campylobacter isolates from turkeys was also reported by Lee
et al. (18).
The high prevalence of tetracycline resistance in Campy-
lobacter isolates from organically raised broilers and turkeys
observed in this study is quite interesting. Although tetracy-
cline had never been used in those organic poultry farms,
tetracycline-resistant Campylobacter strains were present in
four out of five organic poultry farms surveyed in this study.
The high prevalence of tetracycline resistance in Campy-
lobacter isolates from the organic production system was also
reported by other studies (10, 35). Tetracycline-resistant
Campylobacter strains were not limited to the isolates from
organic broilers and turkeys; these strains were also noticed
among Campylobacter isolates from organic dairy cattle (35).
Since tetracyclines have been used as feed additives for live-
stock and poultry for both therapeutic and subtherapeutic pur-
poses for a long period of time (9, 14), it is possible that
Campylobacter may have evolutionally become resistant to this
class of antimicrobials, leading to the widespread distribution
of tetracycline-resistant Campylobacter in animal reservoirs re-
gardless of the production types. As with tetracycline resis-
tance, the occurrence of kanamycin resistance was also ob-
served in Campylobacter strains isolated from organically
raised broilers and turkeys. However, these kanamycin-resis-
tant Campylobacter strains were present mainly in only two
organic poultry farms.
Interestingly, none of the C. jejuni and C. coli plus other
Campylobacter species isolated from both conventionally raised
and organically raised broilers and turkeys in our study was
resistant to gentamicin. This finding is in agreement with pre-
vious studies by other research groups (19, 20), who reported
that no gentamicin resistance was observed among Campy-
lobacter isolates from poultry, except for one study from Spain
(33), indicating that 25% of Campylobacter strains isolated
from broilers were resistant to this antimicrobial. Although
gentamicin was the most commonly used antimicrobial in con-
ventionally raised broilers in this study, it was given to the birds
at the hatchery by subcutaneous injection in the neck region.
Since gentamicin is seldom absorbed in the gut (1) and Campy-
lobacter is rarely present in the intestinal tracts of the birds
during the first week of life, it is not surprising that the use of
gentamicin has little or no impact on the selection of genta-
micin resistance in Campylobacter species.
In this study, the difference in antimicrobial resistance rates
between conventional poultry operations and organic poultry
operations was observed mainly among C. coli and other
Campylobacter species isolates rather than among C. jejuni
isolates. Consistent with other findings (5, 19, 33), the high
prevalence of antimicrobial resistance, particularly to erythro-
mycin, clindamycin, and kanamycin, in this study was much
more common in C. coli and other Campylobacter strains than
in C. jejuni. A coresistance between erythromycin and clinda-
mycin among Campylobacter isolates was also observed in this
study as well as in other studies (19, 33, 38).
In summary, this study revealed significant differences in
antimicrobial-resistant Campylobacter isolates between con-
ventional poultry operations and organic poultry operations.
The results suggest that the practice of antimicrobial usage in
conventional poultry production systems influences the preva-
lence of antimicrobial-resistant Campylobacter organisms in
conventionally raised broilers and turkeys. However, antimi-
crobial usage alone may not be solely responsible for the in-
creased antimicrobial resistance in Campylobacter because
even in the absence of antimicrobial exposure, a high level of
tetracycline resistance was observed in organically raised broil-
ers and turkeys. Similarly, the resistance rates to fluoroquino-
lones were also high in the surveyed conventional broiler flocks
which were not directly exposed to the class of antimicrobials
during the entire production period. These observations sug-
gest that antimicrobial-resistant Campylobacter isolates are sta-
ble and able to transmit and persist in poultry even in the
absence of selection pressure. Together, these findings reveal
the complex nature of the occurrence and spread of antimicrobial
resistance as well as underscore the difficulty in eliminating anti-
microbial-resistant Campylobacter isolates, especially fluoroquin-
olone-resistant strains, from conventional poultry productions. In
addition, this study also further highlights the need for prudent
measures to prevent the occurrence and transmission of antimi-
crobial-resistant Campylobacter in the poultry reservoir.
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